These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38373649)

  • 1. Targeting lipid metabolism of macrophages: A new strategy for tumor therapy.
    Shao N; Qiu H; Liu J; Xiao D; Zhao J; Chen C; Wan J; Guo M; Liang G; Zhao X; Xu L
    J Adv Res; 2024 Feb; ():. PubMed ID: 38373649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
    Qiao X; Hu Z; Xiong F; Yang Y; Peng C; Wang D; Li X
    Lipids Health Dis; 2023 Mar; 22(1):45. PubMed ID: 37004014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment.
    Wang H; Yung MM; Xuan Y; Chen F; Chan W; Siu MK; Long R; Jia S; Liang Y; Xu D; Song Z; Tsui SK; Ngan HY; Chan KK; Chan DW
    Exp Hematol Oncol; 2024 Aug; 13(1):90. PubMed ID: 39198883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Metabolism in Tumor-Associated Macrophages.
    Xiang Y; Miao H
    Adv Exp Med Biol; 2021; 1316():87-101. PubMed ID: 33740245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
    Wang Y; Wang D; Yang L; Zhang Y
    Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of metabolism in the polarization of tumor-associated-macrophages: the mass spectrometry-based point of view.
    De Simone G; Soldani C; Morabito A; Franceschini B; Ferlan F; Costa G; Pastorelli R; Donadon M; Brunelli L
    Front Immunol; 2023; 14():1193235. PubMed ID: 37503340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression.
    Kuznetsova AB; Kolesova EP; Parodi A; Zamyatnin AA; Egorova VS
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
    Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
    Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages].
    Zhao K; Shi RC; Miao HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):45-49. PubMed ID: 33474888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
    Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
    Front Immunol; 2020; 11():1731. PubMed ID: 32849616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and macrophages in the tumor microenvironment.
    Yang H; Kim C; Zou W
    Curr Opin Immunol; 2024 Dec; 91():102491. PubMed ID: 39368171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
    Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
    Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
    Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
    Li L; Tian Y
    Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 20. Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.
    Fernando V; Zheng X; Sharma V; Furuta S
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.